{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:31:37Z","timestamp":1792679497447,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Microbiol"],"DOI":"10.1038\/s41564-017-0063-9","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T11:23:58Z","timestamp":1510917838000},"page":"220-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G"],"prefix":"10.1038","volume":"3","author":[{"given":"Darja","family":"Pollpeter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddy","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Sobala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashika","family":"Coxhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert D.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie M.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-6117","authenticated-orcid":false,"given":"Luis","family":"Apolonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil A.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt M.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7699-2064","authenticated-orcid":false,"given":"Michael H.","family":"Malim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"63_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","volume":"13","author":"T Doyle","year":"2015","unstructured":"Doyle, T., Goujon, C. & Malim, M. H. HIV-1 and interferons: who\u2019s interfering with whom? Nat. Rev. Microbiol. 13, 403\u2013413 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"63_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ni.3156","volume":"16","author":"V Simon","year":"2015","unstructured":"Simon, V., Bloch, N. & Landau, N. R. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat. Immunol. 16, 546\u2013553 (2015).","journal-title":"Nat. Immunol."},{"key":"63_CR3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jmb.2013.10.033","volume":"426","author":"BA Desimmie","year":"2014","unstructured":"Desimmie, B. A. et al. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J. Mol. Biol. 426, 1220\u20131245 (2014).","journal-title":"J. Mol. Biol."},{"key":"63_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","volume":"479\u2013480","author":"RS Harris","year":"2015","unstructured":"Harris, R. S. & Dudley, J. P. APOBECs and virus restriction. Virology 479\u2013480, 131\u2013145 (2015).","journal-title":"Virology"},{"key":"63_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.cub.2004.06.057","volume":"14","author":"KN Bishop","year":"2004","unstructured":"Bishop, K. N. et al. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392\u20131396 (2004).","journal-title":"Curr. Biol."},{"key":"63_CR6","doi-asserted-by":"publisher","first-page":"11220","DOI":"10.1128\/JVI.05238-11","volume":"85","author":"JF Hultquist","year":"2011","unstructured":"Hultquist, J. F. et al. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 85, 11220\u201311234 (2011).","journal-title":"J. Virol."},{"key":"63_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy, A. M., Gaddis, N. C., Choi, J. D. & Malim, M. H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646\u2013650 (2002).","journal-title":"Nature"},{"key":"63_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004609","volume":"11","author":"L Apolonia","year":"2015","unstructured":"Apolonia, L. et al. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1. PLoS Pathog. 11, e1004609 (2015).","journal-title":"PLoS Pathogens"},{"key":"63_CR9","doi-asserted-by":"publisher","first-page":"11841","DOI":"10.1128\/JVI.78.21.11841-11852.2004","volume":"78","author":"K Luo","year":"2004","unstructured":"Luo, K. et al. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J. Virol. 78, 11841\u201311852 (2004).","journal-title":"J. Virol."},{"key":"63_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030015","volume":"3","author":"VB Soros","year":"2007","unstructured":"Soros, V. B., Yonemoto, W. & Greene, W. C. Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog. 3, e15 (2007).","journal-title":"PLoS Pathogens"},{"key":"63_CR11","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/nm945","volume":"9","author":"AM Sheehy","year":"2003","unstructured":"Sheehy, A. M., Gaddis, N. C. & Malim, M. H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404\u20131407 (2003).","journal-title":"Nat. Med."},{"key":"63_CR12","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nm946","volume":"9","author":"M Marin","year":"2003","unstructured":"Marin, M., Rose, K. M., Kozak, S. L. & Kabat, D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med 9, 1398\u20131403 (2003).","journal-title":"Nat. Med"},{"key":"63_CR13","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.1089591","volume":"302","author":"X Yu","year":"2003","unstructured":"Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056\u20131060 (2003).","journal-title":"Science"},{"key":"63_CR14","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1128\/JVI.02587-12","volume":"87","author":"K Gillick","year":"2013","unstructured":"Gillick, K. et al. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4+ T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination. J. Virol. 87, 1508\u20131517 (2013).","journal-title":"J. Virol."},{"key":"63_CR15","doi-asserted-by":"publisher","first-page":"11712","DOI":"10.1128\/JVI.00595-12","volume":"86","author":"PK Phalora","year":"2012","unstructured":"Phalora, P. K., Sherer, N. M., Wolinsky, S. M., Swanson, C. M. & Malim, M. H. HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. J. Virol. 86, 11712\u201311724 (2012).","journal-title":"J. Virol."},{"key":"63_CR16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","volume":"113","author":"RS Harris","year":"2003","unstructured":"Harris, R. S. et al. DNA deamination mediates innate immunity to retroviral infection. Cell 113, 803\u2013809 (2003).","journal-title":"Cell"},{"key":"63_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature01709","volume":"424","author":"B Mangeat","year":"2003","unstructured":"Mangeat, B. et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99\u2013103 (2003).","journal-title":"Nature"},{"key":"63_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature01707","volume":"424","author":"H Zhang","year":"2003","unstructured":"Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94\u201398 (2003).","journal-title":"Nature"},{"key":"63_CR19","doi-asserted-by":"publisher","first-page":"8450","DOI":"10.1128\/JVI.00839-06","volume":"80","author":"KN Bishop","year":"2006","unstructured":"Bishop, K. N., Holmes, R. K. & Malim, M. H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 80, 8450\u20138458 (2006).","journal-title":"J. Virol."},{"key":"63_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000231","volume":"4","author":"KN Bishop","year":"2008","unstructured":"Bishop, K. N., Verma, M., Kim, E. Y., Wolinsky, S. M. & Malim, M. H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4, e1000231 (2008).","journal-title":"PLoS Pathogens"},{"key":"63_CR21","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1074\/jbc.M607298200","volume":"282","author":"RK Holmes","year":"2007","unstructured":"Holmes, R. K., Koning, F. A., Bishop, K. N. & Malim, M. H. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J. Biol. Chem. 282, 2587\u20132595 (2007).","journal-title":"J. Biol. Chem."},{"key":"63_CR22","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1093\/nar\/gkm750","volume":"35","author":"Y Iwatani","year":"2007","unstructured":"Iwatani, Y. et al. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 35, 7096\u20137108 (2007).","journal-title":"Nucleic Acids Res."},{"key":"63_CR23","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1128\/JVI.79.17.10978-10987.2005","volume":"79","author":"B Schrofelbauer","year":"2005","unstructured":"Schrofelbauer, B., Yu, Q., Zeitlin, S. G. & Landau, N. R. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J. Virol. 79, 10978\u201310987 (2005).","journal-title":"J Virol"},{"key":"63_CR24","doi-asserted-by":"publisher","first-page":"11667","DOI":"10.1074\/jbc.M606864200","volume":"282","author":"B Yang","year":"2007","unstructured":"Yang, B., Chen, K., Zhang, C., Huang, S. & Zhang, H. Virion-associated uracil DNA glycosylase-2 and apurinic\/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA. J. Biol. Chem. 282, 11667\u201311675 (2007).","journal-title":"J. Biol. Chem."},{"key":"63_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1128\/JVI.80.2.875-882.2006","volume":"80","author":"SM Kaiser","year":"2006","unstructured":"Kaiser, S. M. & Emerman, M. Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G. J. Virol. 80, 875\u2013882 (2006).","journal-title":"J. Virol."},{"key":"63_CR26","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1128\/JVI.02469-07","volume":"82","author":"MA Langlois","year":"2008","unstructured":"Langlois, M. A. & Neuberger, M. S. Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1. J. Virol. 82, 4660\u20134664 (2008).","journal-title":"J. Virol."},{"key":"63_CR27","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1128\/JVI.00272-07","volume":"81","author":"JL Mbisa","year":"2007","unstructured":"Mbisa, J. L. et al. Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration. J. Virol. 81, 7099\u20137110 (2007).","journal-title":"J. Virol."},{"key":"63_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cub.2004.12.068","volume":"15","author":"EN Newman","year":"2005","unstructured":"Newman, E. N. et al. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr. Biol. 15, 166\u2013170 (2005).","journal-title":"Curr. Biol."},{"key":"63_CR29","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1128\/JVI.02358-09","volume":"84","author":"JL Mbisa","year":"2010","unstructured":"Mbisa, J. L., Bu, W. & Pathak, V. K. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms. J. Virol. 84, 5250\u20135259 (2010).","journal-title":"J. Virol."},{"key":"63_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nchem.1795","volume":"6","author":"KR Chaurasiya","year":"2014","unstructured":"Chaurasiya, K. R. et al. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein. Nat. Chem. 6, 28\u201333 (2014).","journal-title":"Nat. Chem."},{"key":"63_CR31","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1128\/JVI.06594-11","volume":"86","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication. J. Virol. 86, 3777\u20133786 (2012).","journal-title":"J. Virol."},{"key":"63_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006882","volume":"2","author":"WS Hu","year":"2012","unstructured":"Hu, W. S. & Hughes, S. H. HIV-1 reverse transcription. C.S.H. Perspect. Med. 2, a006882 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"63_CR33","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s00018-010-0346-2","volume":"67","author":"A Herschhorn","year":"2010","unstructured":"Herschhorn, A. & Hizi, A. Retroviral reverse transcriptases. Cell Mol. Life Sci. 67, 2717\u20132747 (2010).","journal-title":"Cell Mol. Life Sci."},{"key":"63_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/BF02255218","volume":"2","author":"EJ Arts","year":"1995","unstructured":"Arts, E. J., Li, Z. & Wainberg, M. A. Analysis of primer extension and the first template switch during human immunodeficiency virus reverse transcription. J. Biomed. Sci. 2, 314\u2013321 (1995).","journal-title":"J. Biomed. Sci."},{"key":"63_CR35","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1128\/JVI.75.2.672-686.2001","volume":"75","author":"MD Driscoll","year":"2001","unstructured":"Driscoll, M. D., Golinelli, M. P. & Hughes, S. H. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing. J. Virol. 75, 672\u2013686 (2001).","journal-title":"J. Virol."},{"key":"63_CR36","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1093\/nar\/26.14.3433","volume":"26","author":"GP Harrison","year":"1998","unstructured":"Harrison, G. P., Mayo, M. S., Hunter, E. & Lever, A. M. Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5\u2032 and 3\u2032 of the catalytic site. Nucleic Acids Res. 26, 3433\u20133442 (1998).","journal-title":"Nucleic Acids Res."},{"key":"63_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004281","volume":"10","author":"EY Kim","year":"2014","unstructured":"Kim, E. Y. et al. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog. 10, e1004281 (2014).","journal-title":"PLoS Pathogens"},{"key":"63_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nsmb758","volume":"11","author":"Q Yu","year":"2004","unstructured":"Yu, Q. et al. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11, 435\u2013442 (2004).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"63_CR39","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/pro.2554","volume":"23","author":"N Schormann","year":"2014","unstructured":"Schormann, N., Ricciardi, R. & Chattopadhyay, D. Uracil-DNA glycosylases\u2014structural and functional perspectives on an essential family of DNA repair enzymes. Protein Sci. 23, 1667\u20131685 (2014).","journal-title":"Protein Sci"},{"key":"63_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1098\/rstb.2008.0186","volume":"364","author":"T Visnes","year":"2009","unstructured":"Visnes, T. et al. Uracil in DNA and its processing by different DNA glycosylases. Philos. T. Roy. Soc. B. 364, 563\u2013568 (2009).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0021-9258(19)85067-6","volume":"264","author":"Z Wang","year":"1989","unstructured":"Wang, Z. & Mosbaugh, D. W. Uracil-DNA glycosylase inhibitor gene of bacteriophage PBS2 encodes a binding protein specific for uracil-DNA glycosylase. J. Biol. Chem. 264, 1163\u20131171 (1989).","journal-title":"J. Biol. Chem."},{"key":"63_CR42","doi-asserted-by":"publisher","first-page":"7039","DOI":"10.1128\/JVI.74.15.7039-7047.2000","volume":"74","author":"LM Mansky","year":"2000","unstructured":"Mansky, L. M., Preveral, S., Selig, L., Benarous, R. & Benichou, S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J. Virol. 74, 7039\u20137047 (2000).","journal-title":"J. Virol."},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1128\/JVI.73.2.1682-1688.1999","volume":"73","author":"KE Willetts","year":"1999","unstructured":"Willetts, K. E. et al. DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J. Virol. 73, 1682\u20131688 (1999).","journal-title":"J. Virol."},{"key":"63_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064196","volume":"8","author":"MB Adolph","year":"2013","unstructured":"Adolph, M. B., Webb, J. & Chelico, L. Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase. PLoS ONE 8, e64196 (2013).","journal-title":"PLoS ONE"},{"key":"63_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2144\/05383RV01","volume":"38","author":"TC Voss","year":"2005","unstructured":"Voss, T. C., Demarco, I. A. & Day, R. N. Quantitative imaging of protein interactions in the cell nucleus. Biotechniques 38, 413\u2013424 (2005).","journal-title":"Biotechniques"},{"key":"63_CR46","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1128\/JVI.02237-06","volume":"81","author":"A Burnett","year":"2007","unstructured":"Burnett, A. & Spearman, P. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J. Virol. 81, 5000\u20135013 (2007).","journal-title":"J. Virol."},{"key":"63_CR47","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/sj.emboj.7600246","volume":"23","author":"HL Wiegand","year":"2004","unstructured":"Wiegand, H. L., Doehle, B. P., Bogerd, H. P. & Cullen, B. R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23, 2451\u20132458 (2004).","journal-title":"EMBO J."},{"key":"63_CR48","doi-asserted-by":"publisher","first-page":"38122","DOI":"10.1074\/jbc.C600253200","volume":"281","author":"JE Wedekind","year":"2006","unstructured":"Wedekind, J. E. et al. Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits. J. Biol. Chem. 281, 38122\u201338126 (2006).","journal-title":"J. Biol. Chem."},{"key":"63_CR49","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1128\/JVI.00287-08","volume":"82","author":"S Gallois-Montbrun","year":"2008","unstructured":"Gallois-Montbrun, S. et al. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J. Virol. 82, 5636\u20135642 (2008).","journal-title":"J. Virol."},{"key":"63_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000330","volume":"5","author":"H Huthoff","year":"2009","unstructured":"Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F. & Malim, M. H. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 5, e1000330 (2009).","journal-title":"PLoS Pathogens"},{"key":"63_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12193","volume":"7","author":"X Xiao","year":"2016","unstructured":"Xiao, X., Li, S. X., Yang, H. & Chen, X. S. Crystal structures of APOBEC3G N-domain alone and its complex with DNA. Nat. Commun. 7, 12193 (2016).","journal-title":"Nat. Commun."},{"key":"63_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virusres.2016.12.019","volume":"15","author":"L Menendez-Arias","year":"2017","unstructured":"Menendez-Arias, L., Sebastian-Martin, A. & Alvarez, M. Viral reverse transcriptases. Virus Res. 15, 153\u2013176 (2017).","journal-title":"Virus Res."},{"key":"63_CR53","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4161\/rna.7.6.14115","volume":"7","author":"JG Levin","year":"2010","unstructured":"Levin, J. G., Mitra, M., Mascarenhas, A. & Musier-Forsyth, K. Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol. 7, 754\u2013774 (2010).","journal-title":"RNA Biol."},{"key":"63_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2007.12.017","volume":"134","author":"VP Basu","year":"2008","unstructured":"Basu, V. P. et al. Strand transfer events during HIV-1 reverse transcription. Virus Res. 134, 19\u201338 (2008).","journal-title":"Virus Res."},{"key":"63_CR55","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.1074\/jbc.M211618200","volume":"278","author":"Y Iwatani","year":"2003","unstructured":"Iwatani, Y., Rosen, A. E., Guo, J., Musier-Forsyth, K. & Levin, J. G. Efficient initiation of HIV-1 reverse transcription in vitro. Requirement for RNA sequences downstream of the primer binding site abrogated by nucleocapsid protein-dependent primer\u2013template interactions. J. Biol. Chem. 278, 14185\u201314195 (2003).","journal-title":"J. Biol. Chem."},{"key":"63_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep17680","volume":"5","author":"T Masuda","year":"2015","unstructured":"Masuda, T. et al. Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA. Sci. Rep. 5, 17680 (2015).","journal-title":"Sci. Rep."},{"key":"63_CR57","doi-asserted-by":"publisher","first-page":"13378","DOI":"10.1073\/pnas.1616627113","volume":"113","author":"S Kharytonchyk","year":"2016","unstructured":"Kharytonchyk, S. et al. Transcriptional start site heterogeneity modulates the structure and function of the HIV-1 genome. Proc. Natl Acad. Sci. USA 113, 13378\u201313383 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63_CR58","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1016\/S0021-9258(18)98417-6","volume":"268","author":"GJ Klarmann","year":"1993","unstructured":"Klarmann, G. J., Schauber, C. A. & Preston, B. D. Template-directed pausing of DNA synthesis by HIV-1 reverse transcriptase during polymerization of HIV-1 sequences in vitro. J. Biol. Chem. 268, 9793\u20139802 (1993).","journal-title":"J. Biol. Chem."},{"key":"63_CR59","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/ni.3157","volume":"16","author":"M Altfeld","year":"2015","unstructured":"Altfeld, M. & Gale, M. Jr. Innate immunity against HIV-1 infection. Nat. Immunol. 16, 554\u2013562 (2015).","journal-title":"Nat. Immunol."},{"key":"63_CR60","doi-asserted-by":"publisher","first-page":"37333","DOI":"10.1074\/jbc.M110.133181","volume":"285","author":"J Ahn","year":"2010","unstructured":"Ahn, J. et al. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation. J. Biol. Chem. 285, 37333\u201337341 (2010).","journal-title":"J. Biol. Chem."},{"key":"63_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/viro.1995.1347","volume":"210","author":"WK Steagall","year":"1995","unstructured":"Steagall, W. K., Robek, M. D., Perry, S. T., Fuller, F. J. & Payne, S. L. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology 210, 302\u2013313 (1995).","journal-title":"Virology"},{"key":"63_CR62","doi-asserted-by":"publisher","first-page":"25047","DOI":"10.1074\/jbc.M111.234047","volume":"286","author":"EM Kennedy","year":"2011","unstructured":"Kennedy, E. M. et al. Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase. J. Biol. Chem. 286, 25047\u201325055 (2011).","journal-title":"J. Biol. Chem."},{"key":"63_CR63","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.1073\/pnas.1102943108","volume":"108","author":"N Yan","year":"2011","unstructured":"Yan, N., O\u2019Day, E., Wheeler, L. A., Engelman, A. & Lieberman, J. HIV DNA is heavily uracilated, which protects it from autointegration. Proc. Natl Acad. Sci. USA 108, 9244\u20139249 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63_CR64","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18447","volume":"5","author":"EC Hansen","year":"2016","unstructured":"Hansen, E. C. et al. Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells. eLife 5, 18447 (2016).","journal-title":"Elife"},{"key":"63_CR65","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1073\/pnas.1219702110","volume":"110","author":"AF Weil","year":"2013","unstructured":"Weil, A. F. et al. Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration. Proc. Natl Acad. Sci. USA 110, E448\u2013E457 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63_CR66","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1099\/0022-1317-83-10-2339","volume":"83","author":"R Chen","year":"2002","unstructured":"Chen, R., Wang, H. & Mansky, L. M. Roles of uracil-DNA glycosylase and dUTPase in virus replication. J. Gen. Virol. 83, 2339\u20132345 (2002).","journal-title":"J. Gen. Virol."},{"key":"63_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-45","volume":"5","author":"J Sire","year":"2008","unstructured":"Sire, J., Querat, G., Esnault, C. & Priet, S. Uracil within DNA: an actor of antiviral immunity. Retrovirology 5, 45 (2008).","journal-title":"Retrovirology"},{"key":"63_CR68","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nature02343","volume":"427","author":"M Stremlau","year":"2004","unstructured":"Stremlau, M. et al. The cytoplasmic body component TRIM5\u03b1 restricts HIV-1 infection in Old World monkeys. Nature 427, 848\u2013853 (2004).","journal-title":"Nature"},{"key":"63_CR69","doi-asserted-by":"publisher","first-page":"5514","DOI":"10.1073\/pnas.0509996103","volume":"103","author":"M Stremlau","year":"2006","unstructured":"Stremlau, M. et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5\u03b1 restriction factor. Proc. Natl Acad. Sci. USA 103, 5514\u20135519 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63_CR70","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006940","volume":"2","author":"MH Malim","year":"2012","unstructured":"Malim, M. H. & Bieniasz, P. D. HIV restriction factors and mechanisms of evasion. C.S.H. Perspect. Med. 2, a006940 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"63_CR71","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/v1030873","volume":"1","author":"K Warren","year":"2009","unstructured":"Warren, K., Warrilow, D., Meredith, L. & Harrich, D. Reverse transcriptase and cellular factors: regulators of HIV-1 reverse transcription. Viruses 1, 873\u2013894 (2009).","journal-title":"Viruses"},{"key":"63_CR72","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","volume":"41","author":"JD Salter","year":"2016","unstructured":"Salter, J. D., Bennett, R. P. & Smith, H. C. The APOBEC protein family: united by structure, divergent in function. Trends Biochem Sci 41, 578\u2013594 (2016).","journal-title":"Trends Biochem Sci"},{"key":"63_CR73","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1128\/JVI.02795-06","volume":"81","author":"H Huthoff","year":"2007","unstructured":"Huthoff, H. & Malim, M. H. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and virion encapsidation. J. Virol. 81, 3807\u20133815 (2007).","journal-title":"J. Virol."},{"key":"63_CR74","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1128\/JVI.02526-09","volume":"84","author":"CM Swanson","year":"2010","unstructured":"Swanson, C. M., Sherer, N. M. & Malim, M. H. SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. J. Virol. 84, 6748\u20136759 (2010).","journal-title":"J. Virol."},{"key":"63_CR75","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1128\/JVI.02287-06","volume":"81","author":"S Gallois-Montbrun","year":"2007","unstructured":"Gallois-Montbrun, S. et al. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 81, 2165\u20132178 (2007).","journal-title":"J. Virol."},{"key":"63_CR76","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1128\/JVI.77.10.5810-5820.2003","volume":"77","author":"NC Gaddis","year":"2003","unstructured":"Gaddis, N. C., Chertova, E., Sheehy, A. M., Henderson, L. E. & Malim, M. H. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions. J. Virol. 77, 5810\u20135820 (2003).","journal-title":"J. Virol."},{"key":"63_CR77","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3","volume":"12","author":"DG Myszka","year":"1999","unstructured":"Myszka, D. G. Improving biosensor analysis. J. Mol. Recognit. 12, 279\u2013284 (1999).","journal-title":"J. Mol. Recognit."},{"key":"63_CR78","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1432-0436.2003.07109007.x","volume":"71","author":"Y Chen","year":"2003","unstructured":"Chen, Y., Mills, J. D. & Periasamy, A. Protein localization in living cells and tissues using FRET and FLIM. Differentiation 71, 528\u2013541 (2003).","journal-title":"Differentiation"},{"key":"63_CR79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.copbio.2004.12.002","volume":"16","author":"H Wallrabe","year":"2005","unstructured":"Wallrabe, H. & Periasamy, A. Imaging protein molecules using FRET and FLIM microscopy. Curr. Opin. Biotechnol. 16, 19\u201327 (2005).","journal-title":"Curr. Opin. Biotechnol."},{"key":"63_CR80","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2818.2012.03618.x","volume":"247","author":"W Becker","year":"2012","unstructured":"Becker, W. Fluorescence lifetime imaging\u2014techniques and applications. J. Microsc. 247, 119\u2013136 (2012).","journal-title":"J. Microsc."},{"key":"63_CR81","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1128\/JVI.06597-11","volume":"86","author":"PL Boyer","year":"2012","unstructured":"Boyer, P. L., Clark, P. K. & Hughes, S. H. HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors. J. Virol. 86, 5885\u20135894 (2012).","journal-title":"J. Virol."},{"key":"63_CR82","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1128\/AAC.38.9.1909","volume":"38","author":"PL Boyer","year":"1994","unstructured":"Boyer, P. L., Ding, J., Arnold, E. & Hughes, S. H. Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 38, 1909\u20131914 (1994).","journal-title":"Antimicrob. Agents Chemother."},{"key":"63_CR83","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1529\/biophysj.104.050153","volume":"88","author":"M Peter","year":"2005","unstructured":"Peter, M. et al. Multiphoton-FLIM quantification of the EGFP-mRFP1 FRET pair for localization of membrane receptor-kinase interactions. Biophys. J. 88, 1224\u20131237 (2005).","journal-title":"Biophys. J."},{"key":"63_CR84","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/MCB.25.5.1680-1695.2005","volume":"25","author":"M Parsons","year":"2005","unstructured":"Parsons, M. et al. Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells. Mol. Cell. Biol. 25, 1680\u20131695 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"63_CR85","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1091\/mbc.E06-11-1031","volume":"18","author":"S Prag","year":"2007","unstructured":"Prag, S. et al. Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42. Mol. Biol. Cell 18, 2935\u20132948 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"63_CR86","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1128\/JVI.02680-05","volume":"80","author":"Y Iwatani","year":"2006","unstructured":"Iwatani, Y., Takeuchi, H., Strebel, K. & Levin, J. G. Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. J. Virol. 80, 5992\u20136002 (2006).","journal-title":"J. Virol."},{"key":"63_CR87","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1074\/jbc.M112.424416","volume":"288","author":"AM Bruns","year":"2013","unstructured":"Bruns, A. M. et al. ATP hydrolysis enhances RNA recognition and antiviral signal transduction by the innate immune sensor, laboratory of genetics and physiology 2 (LGP2). J. Biol. Chem. 288, 938\u2013946 (2013).","journal-title":"J. Biol. Chem."},{"key":"63_CR88","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1039\/C3CS60201J","volume":"43","author":"H Hwang","year":"2014","unstructured":"Hwang, H. & Myong, S. Protein induced fluorescence enhancement (PIFE) for probing protein\u2013nucleic acid interactions. Chem. Soc. Rev. 43, 1221\u20131229 (2014).","journal-title":"Chem. Soc. Rev."},{"key":"63_CR89","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.1168352","volume":"323","author":"S Myong","year":"2009","unstructured":"Myong, S. et al. Cytosolic viral sensor RIG-I is a 5\u2032-triphosphate-dependent translocase on double-stranded RNA. Science 323, 1070\u20131074 (2009).","journal-title":"Science"},{"key":"63_CR90","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature00862","volume":"418","author":"SK Petersen-Mahrt","year":"2002","unstructured":"Petersen-Mahrt, S. K., Harris, R. S. & Neuberger, M. S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99\u2013103 (2002).","journal-title":"Nature"}],"container-title":["Nature Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41564-017-0063-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-017-0063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41564-017-0063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T02:34:38Z","timestamp":1671762878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41564-017-0063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1038\/s41564-017-0063-9","relation":{},"ISSN":["2058-5276"],"issn-type":[{"value":"2058-5276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]},"assertion":[{"value":"9 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}